Iovance Biotherapeutics CFO Resignation and Interim Appointment
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Iovance Biotherapeutics ( (IOVA)) just unveiled an announcement.
On June 30, 2025, Iovance Biotherapeutics announced the resignation of Jean-Marc Bellemin as Chief Financial Officer, effective immediately, with Matthew W. Rosinack stepping in as interim Principal Financial Officer and Principal Accounting Officer. Rosinack, who has extensive experience in finance roles at various biotechnology and medical device companies, has been with Iovance since September 2021 and will temporarily fill the role as the company navigates this transition.
The most recent analyst rating on (IOVA) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Iovance Biotherapeutics stock, see the IOVA Stock Forecast page.
Spark's Take on IOVA Stock
According to Spark, TipRanks' AI Analyst, IOVA is a Neutral.
Iovance Biotherapeutics' stock score reflects its current growth phase marked by significant revenue increases and strong equity, offset by ongoing losses and cash flow challenges. The technical indicators suggest bearish momentum, while mixed earnings call sentiments and recent corporate events add moderate risk. The valuation is impacted by negative earnings, typical for a company investing heavily in growth.
To see Spark's full report on IOVA stock, click here.
More about Iovance Biotherapeutics
Average Trading Volume: 13,697,268
Technical Sentiment Signal: Sell
Current Market Cap: $581M
See more data about IOVA stock on TipRanks' Stock Analysis page.
Disclaimer & Disclosure Report an Issue
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Post
an hour ago
- National Post
Trump signs tax-and-spending cut bill at White House ceremony, calls it 'biggest victory yet'
U.S. President Donald Trump speaks on the South Lawn of the White House in Washington, DC on July 4, 2025. Photo by BRENDAN SMIALOWSKI/AFP via Getty Images U.S. President Donald Trump signed his US$3.4 trillion budget bill into law Friday, enshrining an extension of tax cuts, temporary new breaks for tipped workers and funding to crack down on illegal immigration. THIS CONTENT IS RESERVED FOR SUBSCRIBERS Enjoy the latest local, national and international news. Exclusive articles by Conrad Black, Barbara Kay and others. Plus, special edition NP Platformed and First Reading newsletters and virtual events. Unlimited online access to National Post. National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles including the New York Times Crossword. Support local journalism. SUBSCRIBE FOR MORE ARTICLES Enjoy the latest local, national and international news. Exclusive articles by Conrad Black, Barbara Kay and others. Plus, special edition NP Platformed and First Reading newsletters and virtual events. Unlimited online access to National Post. National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on. Daily puzzles including the New York Times Crossword. Support local journalism. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors The package encompasses a suite of priorities Trump campaigned on in 2024 — and its enactment at a White House ceremony represents a major political victory for the president whose second term was marked until now by executive rather than legislative action. The legislative milestone reinforces Trump's grip on the Republican Party, whose Capitol Hill leaders muscled the bill through the House and Senate this week. To reach his July 4 target date, Trump worked the phones and summoned some lawmakers to the White House in a pressure campaign to win over key holdouts. Get a dash of perspective along with the trending news of the day in a very readable format. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again 'It's really promises made, promises kept,' Trump said before signing the measure at an outdoor ceremony preceded by an Air Force flyover. After citing what he said were his efforts to restore American strength on the world stage, he called the bill 'the biggest victory yet.' Republican legislative leaders overcame narrow margins, unified opposition from congressional Democrats and objections by fiscal conservatives and moderates to pass the bill before Trump's deadline, which coincided with the Independence Day holiday. Yet the legislative success comes with political risks for the president and Republicans with consequences that could rumble for years. The fiscal package imposes steep cuts and new administrative procedures on nutrition assistance and health programs that provide a safety net for working and unemployed Americans. The nonpartisan Congressional Budget Office estimates the changes will push some 11.8 million Americans off the Medicaid health insurance program. Others have warned that reduced hospital payments could shut down rural medical facilities. The cuts have helped sour the public on Trump's plan, with polls showing it's unpopular. Some Senate Republicans have warned the party could face a backlash at the ballot box. Democrats have vowed to wield the bill against Republicans in the buildup to next year's midterm elections. Trump and his supporters cast the measure as fuel for an economic renaissance, shrugging off nonpartisan projections that the package will drive up the national debt. 'Our country is going to be a rocketship economically,' Trump said, while dismissing polls that suggest the measure is unpopular.
Globe and Mail
3 hours ago
- Globe and Mail
DBS Sticks to Its Buy Rating for BYD Co (BYDDF)
DBS analyst maintained a Buy rating on BYD Co today and set a price target of HK$164.00. The company's shares closed yesterday at $15.63. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. BYD Co has an analyst consensus of Strong Buy, with a price target consensus of $22.89. Based on BYD Co's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $170.36 billion and a net profit of $9.15 billion. In comparison, last year the company earned a revenue of $124.94 billion and had a net profit of $4.57 billion
CTV News
3 hours ago
- CTV News
Patriotism, protests mark Washington's U.S. Independence Day Parade
Comments by the U.S. ambassador to Canada is casting doubt on whether a trade deal between Canada and the U.S. can be reached in July. Adrian Ghobrial explains.
